MedPath

The assessment of effectiveness of respiratory muscle training (I M T)and aerobic training in patients with pulmonary disease

Not Applicable
Conditions
Chronic bronchitis-emphysema.
Emphysema Excl.: emphysema-Simple and mucopurulent chronic bronchitis
J41-J43
Registration Number
IRCT20180205038633N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
68
Inclusion Criteria

Satisfaction to participate in the study Getting Grade 2 or 3 Based on GOLD Criteria Age 40 to 70 years Failure to have previous known disease, such as heart disease (such as C.H.F and coronary artery disease), or disease of the lungs (E.S.R.D and C.R.F), and liver (cirrhosis of the liver, cancer, etc.) Lack of other pulmonary diseases, such as lung cancer, plural disease, or musculature involvement. The lack of extreme limbs that prevent aerobic exercise Lack of pulmonary surgery in the last 12 months Recent fracture failure at the level of ribs (6 months) No history of psychotropic disease and related drugs and alcohol and psychotropic substances

Exclusion Criteria

Failure to have previous known disease, such as heart disease (such as C.H.F and coronary artery disease), or disease of the lungs (E.S.R.D and C.R.F), and liver (cirrhosis of the liver, cancer, etc.)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spirometric FEV 1 Index - Quality of Life Indicator score. Timepoint: Beginning of study - Week 4 - Week 8. Method of measurement: Lung Spirometry - St. George's Quality of Life Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath